Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”
In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires
PCI Files Application For Research Base COP
Eight applications Received For NSABP chairman
Pitt Criticizes NCI Stance On Repayment For Fraud Trials
Broder, Herberman, Decline To Coauthor Reanalysis of Data
“I Can’t Permit Destruction of NSABP,” Fisher Writes
Herberman: Progress Made To Stabilize NSABP
Trending Stories
- Trump backs off the 100% pharma tariffs ultimatum
- ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- White House announces “TrumpRx,” a new prescription drug website
- Pulitzer-winning healthcare reporter Laurie McGinley on her shift to advocacy work with PACR
- The Directors: Steven Artandi and Eric Winer on how looming policy changes “reverberate” through oncology
“Even when funding gets restored and if the H-1B visa threat doesn’t materialize, it creates an environment where especially young people become uncertain.”